Therefore, while the initial proof-of-concept was done in CDI, the model is a widely applicable tool for the quantitative analysis of the metabolic and immunological mechanisms of CD4+ T cells in the context of a wide range of inflammatory, infectious, metabolic, neurodegenerative, and autoimmune diseases. The gene discussed is CD4; the disease is autoimmune disease.